![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Ogawa Lisa M. Fink Bova Carol
Publisher: Informa Healthcare
ISSN: 1082-6084
Source: Substance Use & Misuse, Vol.44, Iss.7, 2009-06, pp. : 915-933
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Painful decision-making at FDA
By Nelson Lewis S Perrone Jeanmarie Juurlink David N
Expert Opinion on Drug Safety, Vol. 13, Iss. 4, 2014-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The role of pharmacoeconomics in decision-making
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 272, 2000-01 ,pp. :